BRIEF published on 04/03/2026 at 07:05, 1 month 25 days ago Innate Pharma to Join Kempen Life Sciences Conference Biotechnology Investor Meetings Innate Pharma Cancer Immunotherapies Kempen Conference
BRIEF published on 04/03/2026 at 07:05, 1 month 25 days ago Innate Pharma participera à la Kempen Life Sciences Conference Conference Innate Pharma Biotechnologies Immunothérapies Kempen Life Sciences
BRIEF published on 04/03/2026 at 07:05, 1 month 25 days ago Innate Pharma will participate in the Kempen Life Sciences Conference Biotechnology Conference Innate Pharma Immunothérapies Kempen Life Sciences
PRESS RELEASE published on 04/03/2026 at 07:00, 1 month 25 days ago Inside Information / Other news releases Innate Pharma to participate in the Kempen Life Sciences Conference on April 15-16, 2026, in Amsterdam, Netherlands. The company is developing immunotherapies for cancer patients Biotechnology Innate Pharma Immunothérapies Cancer Patients Kempen Life Sciences Conference
PRESS RELEASE published on 04/03/2026 at 07:00, 1 month 25 days ago Informations privilégiées / Autres communiqués Innate Pharma participera à la conférence Kempen Life Sciences à Amsterdam, Pays-Bas, du 15 au 16 avril 2026, pour présenter ses traitements d'immunothérapies contre le cancer Conference Immunothérapie Cancer Innate Pharma Kempen Life Sciences
BRIEF published on 12/11/2025 at 07:05, 5 months 17 days ago Innate Pharma Announces 2026 Financial Calendar Biotechnology Investor Information Innate Pharma Financial Schedule 2026 Key Dates
BRIEF published on 12/11/2025 at 07:05, 5 months 17 days ago Innate Pharma révèle son calendrier financier 2026 Biotechnologie Calendrier Financier Immunothérapie Innate Pharma Résultats 2026
BRIEF published on 12/11/2025 at 07:05, 5 months 17 days ago Innate Pharma annonce son calendrier financier pour 2026 Biotechnologie Calendrier Financier Informations Pour Les Investisseurs Innate Pharma Dates Clés De 2026
BRIEF published on 12/11/2025 at 07:05, 5 months 17 days ago Innate Pharma reveals its 2026 financial calendar Biotechnology Financial Calendar Immunotherapy Innate Pharma 2026 Results
PRESS RELEASE published on 12/11/2025 at 07:00, 5 months 17 days ago Informations privilégiées / Autres communiqués Innate Pharma publie son calendrier financier pour 2026, incluant la publication des résultats annuels et semestriels, ainsi que des chiffres d'affaires trimestriels Chiffre D'affaires Calendrier Financier Résultats Annuels Innate Pharma Immunothérapies
Published on 05/28/2026 at 09:05, 59 minutes ago Tocvan Intersects Three New Gold-Silver Zones at Gran Pilar Project Exploration Drilling; Provides Pilot Mine Development Update
Published on 05/28/2026 at 09:01, 1 hour 3 minutes ago Discovery Energy Metals Corp. Mobilizes Crews for Surface Sampling Program at Crystal Lake Cu-Mo Project, British Columbia
Published on 05/28/2026 at 09:00, 1 hour 4 minutes ago Applications are Open for the 2026 Semmelweis-Richter Journalism Award Until June 9th
Published on 05/28/2026 at 08:00, 2 hours 4 minutes ago Touchstone Exploration Provides An Operational Update
Published on 05/28/2026 at 09:45, 19 minutes ago Powering Macau's Smart Future with AI —MACAU Pass and Ant Bank (Macao) Partner with Alibaba Ecosystem to Showcase Smart City Vision at BEYOND Expo
Published on 05/28/2026 at 09:30, 34 minutes ago Topadur Pharma AG Adds Senior Board Expertise with Appointment of Dr. Felix R. Ehrat and Dr. Peter Jager
Published on 05/28/2026 at 09:30, 34 minutes ago M2care and ZEISS Ventures Support Maculaser Oy to Advance Pioneering Temperature-Controlled Retinal Laser Therapy
Published on 05/28/2026 at 09:30, 34 minutes ago M2care et ZEISS Ventures soutiennent Maculaser Oy pour accélérer le développement d’une thérapie laser rétinienne innovante à contrôle de température
Published on 05/28/2026 at 09:19, 44 minutes ago u-blox expands collaboration with Nordic Semiconductor, introducing ALMA-B2 modules with low-latency Edge ML capabilities
Published on 05/28/2026 at 08:45, 1 hour 19 minutes ago Appointment of Mikael Frenkian as Chief Executive Officer of Baikowski
Published on 05/28/2026 at 08:45, 1 hour 19 minutes ago Nomination de Mikael Frenkian en qualité de Directeur Général de Baikowski
Published on 05/28/2026 at 08:30, 1 hour 34 minutes ago Cegedim Business Services renforce sa conformité et sa sécurité avec deux distinctions majeures
Published on 05/27/2026 at 23:00, 11 hours 4 minutes ago BIOPHYTIS MODIFIE SA LIGNE DE FINANCEMENT AVEC HEXAGON CAPITAL FUND POUR RENDRE RENOUVELABLE SA CAPACITE DE TIRAGE DE 2M€
Published on 05/27/2026 at 23:00, 11 hours 4 minutes ago BIOPHYTIS CHANGES ITS FINANCING AGREEMENT WITH HEXAGON CAPITAL FUND TO ENSURE ITS €2 MILLION FACILITY IS RENEWABLE
